Results-In SJL, C3H/He, DBA/2, and C57BIJ6 infected mice, severe to moderlate chronic active gastritis was observed only in the body of the stomach, which increased in severity over time with specialised cells in the body glands being replaced. As the severity of this damage in the body increased and atrophic changes were seen, the level of bacterial colonisation of the antrum decreased. In contrast, in BALB/c and CBA mice, there was only mild gastritis in the antrum, no remarkable changes were detected in their body mucosa, and no atrophy was seen over time. In both these strains of mice, heavy bacterial colonisation was seen, which tended to increase over the period of the experiment. Of particular importance in this experiment was that bacterial colonisation was mainly restricted to the antrum yet the atrophy, when present, was only observed in the body of the stomach. H pyloni infected C3HIHe mice showed moderate colonisation of the antrum, which persisted up to six months with little development of atrophy. In contrast, H pylorn in C57BL/6 mice showed excellent colonisation of the antrum at two months but six months after infection there was moderate to severe body atrophy, which was associated with a loss of bacteria from the antrum. Conclusions-These findings challenge current concepts of the development of Helicobacter induced atrophy in that active chronic gastritis of antrum or the body mucosa, or both, is not a prerequisite. They also suggest an autoimmune basis for the pathology although no autoantibody or antibody to the H'IK' ATPase was detected. Loss of infecting helicobacters from the stomach together with development of an atrophic gastritis in the body ofthe stomach is similar to the pattern found in certain H pylori infected human subjects.
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In 1983 Pelayo Correa proposed a sequence of events leading to the development of gastric adenocarcinoma.' Active chronic gastritis caused by some unexplained environmental factor progressed to multifocal atrophic gastritis with loss of chief cells and parietal cells and the appearance of intestinal metaplasia. Increased cell turnover in the atrophic stomach, together with the hypochlorhydria resulting from parietal cell loss, created a gastric milieu susceptible to the effect of carcinogens possibly generated by overgrowing of nitrifying bacteria. If certain dietary factors were present, for example, high salt intake and low vitamin C consumption the scene was set for the development of adenocarcinoma. The discovery of Helicobacter pylori provided the missing link in the Correa pathway. Here was the environmental factor responsible for the active/chronic gastritis. Epidemiological evidence has accumulated providing enough proof of H pylori as a causal agent in gastric cancer that a working party of the International Agency for Research on Cancer (IARC) classified the bacterium as a Class I carcinogen. 2 The concept of a continuum of H pylori induced inflammation worsening in severity from active/chronic gastritis to atrophic gastritis is now generally accepted as the scenario leading to gastric cancer. Variation in the severity of the gastritis has been explained by the existence of particular virulent strains of H pylori, that carry the marker gene cagA. 3 4 Consistent with this concept, cagA positive strains of H pylori induce greater recruitment of neutrophils via increased production of the inflammatory cytokine interleukin 8 by gastric epithelial cells.5 6 Another feature of atrophic gastritis is that H pylori tends to be lost from the stomach in advanced disease.7 Some claimed the lack of association of concurrent H pylori infection and atrophy as evidence against a causal link. Others suggested this was due to a change in the gastric environment such that it had become hostile to survival of the bacterium in particular, a lack of attachment sites due to intestinalisation of the gastric mucosa. The role of the host factors in the scenario leading to gastric atrophy has been largely ignored. In 1993 we published an animal model of atrophic gastritis, namely longterm infection in a conventional strain of Quackenbush/Swiss (QS) mice with a close relative of H pylorn, Helicobacter felis.8 Subsequently we examined longterm infection of the same strain of bacterium in a different strain of mice, BALB/c. These animals had no gastritis but after 22 months did develop lesions equivalent to low grade B-cell lymphomas.9 A striking feature of these two experiments was the completely different pathology seen in the two strains of mice to longterm exposure to the same bacterium. Differences in host factors were the only explanation. Therefore it was decided to examine the development of gastritis in a number of different strains of mice, to explore the development of atrophic gastritis, and the influence of these host factors. Six strains were selected from the same animal house to eliminate differences due to variations in intestinal microflora. Special emphasis in this study was given to the development of antral gastritis and a mapping of bacterial colonisation as these had not previously been assessed in longterm studies and were important with respect to H pylori induced atrophy in the human. The development of an H pylori mouse model later in this study, using a human strain of the bacterium adapted by multiple passage in mice over six months, allowed us to find out if H pylori would induce atrophy in a mouse model.
Methods

ANIMALS
Six week old female inbred Specific Pathogen Free (SPF) mice of six different strains were obtained from the same institute (Walter and Elisa Hall Institute, Melbourne, Australia), the detail of these mice strains is shown in Table I .
All mice were maintained in the animal house at the School of Microbiology and Immunology, The University of New South Wales. They were fed a diet of sterilised commercial pellets (Lab Feed, Sydney, NSW) and drinking water was given ad libidum.
For each strain, 24 mice were infected with H felis and six mice served as uninfected controls. In addition, groups of 10 C3H/He and C57/BLI6 mice were infected with H pylori. All protocols involving animal experi- The total number of slides was 216. All slides were scored independently by two of us (TS and MD), interobserver differences were found to be negligible. The degree of gastritis was determined using the scoring system described in Table II . Antrum and body were each graded for 'chronic inflammation' characterised by infiltration of mononuclear cells 'activity' by presence of polymorphonuclear leucocytes, and atrophy by loss of specialised There was a severe chronic gastritis with pronounced activity in the body of the stomachs. One month after inoculation the body glands showed loss of parietal and chief cells and replacement by proliferating cells or mucus secreting cells, or both (Fig IA) . Microabscesses in gastric pits were observed in some animals from two months after inoculation (Fig 1B) . In contrast with these dominant pathological lesions in the body, only a mild to moderate degree of inflammation was observed in the antrum with no atrophic or metaplastic changes throughout the experiment (Fig 1 C) .
In the C3H/He strain of mice, the severity of gastritis increased with time and, by six months, all animals had severe gastritis with numerous chronic inflammatory cells in the lamina propria and submucosa in the body. Atrophic changes were especially prominent, in this strain of mice at six months after infection (Fig 2A) . The glandular specialised cells were replaced by proliferating zone cells and mucus secreting epithelial cells, and these proliferating glands breached the muscularis mucosae in some mice. Isolated foci of atypical branching and dysplastic glands were observed (Fig 2B) . Once again only mild to moderate chronic inflammation was seen in the antrum (Fig 2C) .
Mice of the DBA/2 strain had a moderate gastritis by one to two months after inoculation ofthe Hfelis. At six months, there was intensive infiltration by mononuclear inflammatory cells and polymorphs into the mucosa and submucosa and this was limited to the body. Atrophy with loss of parietal cells and the appearance of hyperplastic glands penetrating through the muscularis mucosae was a feature of some mice (Fig 3A) .
The C57BL'6 mice also had a moderate degree of active gastritis. Loss of specialised cells at six months was observed in six mice with extensive hyperproliferation and moderate to severe glandular replacement in the body (Fig 3B) . This was the most varied group with four of 10 mice showing little destructive inflammation.
BALB/c mice had negligible gastritis at one and two months after infection, as observed previously. By six months, a mild degree of cellular infiltration was observed only in the antrum around gastric pits colonised by Hfelis. No atrophic changes occurred in the corpus mucosa of these animals.
The least inflammation following H felis infection was seen in the CBA mice, which showed no gastritis in the body (Fig 4A) or antrum (Fig 4B) during the whole term of the experiment despite excellent colonisation ( Fig  4C) .
Uninfected control mice of each of the six strains used remained Hfelis free over the time of this study, and showed no notable changes in their gastric mucosa. had small numbers of Hfelis only in the antrum throughout the experiment. Many C3H/He animals had moderate colonisation in their antrum at one and two months, but few bacteria were detected at six months. DBA/2 mice also had heavy colonisation in the antrum and cardia at one and two months but the bacteria had disappeared at six months. While most C57BIJ6 mice had heavy colonisation in antrum, body, and cardia at one and two months; only four mice had heavy colonisation in the antrum at six months. The mice with atrophy were the animals found to have lost the infection. In contrast with the four strains above that all showed significant pathology and appeared to lose their helicobacters, in both the BALB/c and CBA strains, mice that showed virtually no pathology associated with infection, all mice have heavy colonisation in their antrum throughout the experiment, with moderate colonisation of the cardia. Indeed, there seemed to be an increase in colonisation in these animals with time.
All strains of mice showed very little colonisation of the body of the stomach at any time point after infection. At the beginning mice had good antral colonisation but, as atrophy developed, their number in the antrum declined. There was thus a negative correlation between antral colonisation and body atrophy. In Table IV , it appears as though the figures for the SJL and C57BIJ6 mice are in conflict with the general rule. This is not the case. With respect to the SJL mouse, major pathology develops rapidly -that is, at one month there is already substantial atrophy and the level of colonisation is much reduced. Using a three point scale as described in the Methods and averaging the results per mouse, a grading of 0.3 means virtually no bacteria are seen. The results with the C57BI/6 mice do seem inconsistent but this relates (as pointed out above) to the variable pathology in these mice, four of 10 mice showing virtually no atrophy. Also in this group the pathology (when present) develops early and consequently the level of colonisation is lower than other strains. This together with the effect of averaging seems to show no influence of atrophy on colonisation. In fact, looking at individual mice within this group the observation holds upthat is, in the four mice without atrophy there is still moderate colonisation of the antrum. Table V shows the serum levels of anti-Hfelis antibody (IgG) measured by ELISA. All infected mice had significantly higher levels of antibody compared with uninfected control mice in each strain. There was a tendency for the levels of antibody to increase with time after infection, however there was no correlation between the severity of the inflammatory response and the level of antibody. The only strain of mice that appeared to have different levels of anti-H felis antibody were the CBA mice, which had a reduced response. Table VI shows the results of assessment of sample mice of various strains for antibody Table VII shows the severity of gastritis in two strains of mice infected with Hpylori. The most severe degree of gastritis after Hpylori infection occurred in the C57BL/6 strain, with a moderate to severe chronic gastritis with activity detectable in the corpus of the stomach ( Fig  5A) . Interestingly, there was not the variability in pathology in the C57/BL/6 mice colonised with Hpylori compared with that observed with Hfelis. Six months after infection body glands showed moderate loss ofparietal and chief cells and replacement with proliferating cells or mucus secreting cells, or both (Fig 5B) . Microabscesses in gastric pits were also seen. In contrast, only a mild degree of inflammation was observed in the antrum with no atrophic or metaplastic changes detected (Fig 5C) .
SEROLOGY OF INFECTED MICE
ASSESSMENT OF AUTOIMMUNITY IN H FELIS INFECTED MICE
The C3H/He mice exhibited a mild degree of cellular infiltration following a six month infection (Fig 5D) what we now know about the colonisation patterns of Hfelis in mice, the distribution of gastritis is anomalous.12 H felis has a more limited ecological niche in the stomach than H pylori. The bacterium is mainly restricted to the antrum of the stomach and the cardia equivalent -that is, the three to four gastric glands immediately distal to the squamocolumnar junction close to the oesophagus and the stratified epithelial lined rumen-like compartment of the mouse stomach. The antrum and cardia have one feature in common; the absence of parietal cells. We have argued elsewhere, that this is due to the sensitivity of the bacterium to local acid production.13 One exception to the poor colonisation of the body mucosa by H felis was in the C57BL/6 mice, which had moderate to heavy colonisation. This is an interesting difference that warrants further investigation but does detract from the main observation that in general progressive changes occurred in the presence of the lightest bacterial load. Although the antrum is the preferred habitat of Hpylori in the human stomach the organism is seen overlying the body. The atrophic and metaplastic gastritis reported in this paper occurs where few bacteria are seen and yet the organism can readily be seen in the antrum in the early stages of infection. This means that the damage seen in body mucosa cannot be due to inflammatory reactions directed against the bacterium itself, otherwise antral destruction would be seen. One explanation for this phenomenon is that the damage results from an autoimmune response directed against gastric tissue and triggered by the presence of longterm Hfelis infection.
Gastric tissue is known to be susceptible to autoimmune attack. In the human, chronic atrophic gastritis of the corpus mucosa (type A gastritis), is the underlying basis for pernicious anaemia and is characterised by the generation of autoantibodies against the H+/K' ATPase enzyme, the gastric proton pump of the parietal cell, together with mononuclear cell infiltration within the gastric mucosa.14 15 However, atrophy with some of the features seen in humans does occur. Importantly this aspect of helicobacter induced inflammation is host dependent. In the human with more bacteria throughout the corpus mucosa and gastritis consistently in the antrum, it is very difficult to dissociate these two entities. These mouse models allow that to be done. The results of the small scale experiment with our mouse adapted strain of H pylori show that the same phenomenon occurs confirming the relevance of the Hfelis data.
Humans infected with H pylori who develop severe gastritis in the body accompanied by loss of acid secretion lose the bacterium.7 The same is seen here in the longterm H felis and Hpylori infected mice. As the atrophy develops the infecting organism is lost from the stomach. In C3H/He, C57BL16 and DBA/2 mice at the last time point examined H felis was not present. SJL mice were never well colonised. In contrast, a high rate of colonisation was seen in BALB/c and CBA mice throughout the entire experiment. Thus, the degree of H felis colonisation in mice was inversely proportional to the severity of the gastritis. One explanation for this observation could be that immunity against the bacteria was increased because of the inflammation and so an effective antibacterial state was induced with time. This would seem unlikely given the inability of normal immune responses to eliminate Hpylori from infected people and the finding that there was no difference in the serological responses to H felis in any mice except the CBA mice, which did have a reduced response. The other explanation could be that local environmental changes induced by the atrophy could be making the stomach inhospitable for Hfelis or H pylori. This could result from competition due to overgrowing other bacteria associated with a hypochlorhydric state or from the cidal effects of a relatively alkaline environment on a bacterium adapted to survival in the presence of some acid. Similar arguments have been suggested for the loss of H pylori from humans with atrophic gastritis.7
Why are there such striking differences in response between mouse strains? One explanation could relate to the immunoreactivity of each strain. Mouse strains of varying haplotypes were selected for this experiment in anticipation of this hypothesis (H-2 complex: major histocompatibility I and II). But C3H/ He and CBA strains belong to the H-2k haplotypes while BALB/c and DBA/2 strains belong to H-2d haplotype. The significant differences in the severity and type of gastritis between these identical H-2 complex strains suggests there is no relation between severity of gastritis and H-2 complex. Another explanation for the difference relates to prior antigen exposure. However, the mouse strains were selected from the same animal house and so it is probable that the gut microbiotas are similar but this has not been proved to date. Much more comparative work is needed before we understand the true nature of these differences in host responsiveness. Why little or no inflammation is seen in the antrum of any of the mouse strains infected with either Hfelis or the cagA positive mouse adapted Hpylori strain is also a mystery. Indeed, true antral active/ chronic gastritis is rarely seen in any helicobacter infected animal of any species other than the human.
A short-term study of H felis infection in BALB/C, C3H/He, and C57BLJ6 mice has recently been reported by Mohammadi and colleagues.24 They demonstrated differences in pathology at 11 weeks similar to our study.
They noted BALB/c mice showed little inflammation whereas C3H/He and C57BL/6 animals had significant scores although atrophy had not yet developed. C57BL16 has 10 times more bacteria in the body as was found here. Additionally, they studied a series of congenic mice and concluded that there are contributions by both MHC and non-MHC genes to helicobacter induced inflammation.
The results from these animal studies challenge the conventional wisdom regarding the evolution of atrophic gastritis and suggest that host dependent autoimmune type mechanisms could contribute. Rather than atrophy being an extreme end point of a continuum of inflammation starting with acute gastritis, leading through active/chronic gastritis to atrophic gastritis, an independent mechanism of induction of multifocal atrophic gastritis may occur in some people. In the human this atrophy is seen together with the chronic gastritis resulting from direct action of the bacteria and so the two phenomena cannot be distinguished. The H felis and H pylori mouse models will allow investigation of the mechanism of parietal and chief cell replacement, reasons for helicobacter loss in the atrophic stomach, and identification of the host factors responsible for host dependent atrophy. This work was supported by a grant from the National Health and Medical Research Council, Australia and Astra Hassle, Sweden. Dr Sagakami was funded through the Vehara Foundation Scholarship of the Taisho Foundation.
